Evidence map›Paper›PMID 34575614›Full record

ArticleJournal of personalized medicine2021

Metabolomic Biomarker Candidates for Skeletal Muscle Loss in the Collagen-Induced Arthritis (CIA) Model.

Paulo V G Alabarse, Jordana M S Silva, Rafaela C E Santo, Marianne S Oliveira, Andrelise S Almeida, Mayara S de Oliveira, Mônica L Immig, Eduarda C Freitas, Vivian O N Teixeira, Camilla L Bathurst and 5 more

Open access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Phenolic-Compound-RichNutrients · 2022
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Paulo V G AlabarseVA San Diego Healthcare System, Veteran Medical Research Foundation, San Diego, CA 92161, USA.ORCID 0000-0002-9721-9302
Jordana M S SilvaHospital de Clínicas de Porto Alegre, Serviço de Reumatologia, Laboratório de Doenças Autoimunes, Porto Alegre 90035-903, Brazil.
Rafaela C E SantoHospital de Clínicas de Porto Alegre, Serviço de Reumatologia, Laboratório de Doenças Autoimunes, Porto Alegre 90035-903, Brazil.ORCID 0000-0002-5518-3479
Marianne S OliveiraHospital de Clínicas de Porto Alegre, Serviço de Reumatologia, Laboratório de Doenças Autoimunes, Porto Alegre 90035-903, Brazil.
Andrelise S AlmeidaHospital de Clínicas de Porto Alegre, Serviço de Reumatologia, Laboratório de Doenças Autoimunes, Porto Alegre 90035-903, Brazil.
Mayara S de OliveiraHospital de Clínicas de Porto Alegre, Serviço de Reumatologia, Laboratório de Doenças Autoimunes, Porto Alegre 90035-903, Brazil.
Mônica L ImmigHospital de Clínicas de Porto Alegre, Serviço de Reumatologia, Laboratório de Doenças Autoimunes, Porto Alegre 90035-903, Brazil.
Eduarda C FreitasHospital de Clínicas de Porto Alegre, Serviço de Reumatologia, Laboratório de Doenças Autoimunes, Porto Alegre 90035-903, Brazil.
Vivian O N TeixeiraHospital de Clínicas de Porto Alegre, Serviço de Reumatologia, Laboratório de Doenças Autoimunes, Porto Alegre 90035-903, Brazil.
Camilla L BathurstQueen Elizabeth Hospital and National Institute for Health Research, Birmingham Biomedical Research Centre, University of Birmingham, Birmingham B15 2TT, UK.ORCID 0000-0003-1438-5960
Claiton V BrenolHospital de Clínicas de Porto Alegre, Serviço de Reumatologia, Laboratório de Doenças Autoimunes, Porto Alegre 90035-903, Brazil.
Lidiane I FilippinUniversidade La Salle, Canoas 92010-000, Brazil.
Stephen P YoungQueen Elizabeth Hospital and National Institute for Health Research, Birmingham Biomedical Research Centre, University of Birmingham, Birmingham B15 2TT, UK.ORCID 0000-0002-6355-3361
Priscila S LoraUniversidade do Vale do Rio dos Sinos, São Leopoldo 93022-750, Brazil.
Ricardo M XavierHospital de Clínicas de Porto Alegre, Serviço de Reumatologia, Laboratório de Doenças Autoimunes, Porto Alegre 90035-903, Brazil.
Hospital de Clínicas de Porto Alegre · BRNational Institute for Health Research · GBUniversidade do Vale do Rio dos Sinos · BRUniversidade La Salle · BRVA San Diego Healthcare System · US

Funding

Hospital de Clínicas de Porto Alegre 14-0297
6 · The paper itself

Abstract

There is no consensus for diagnosis or treatment of RA muscle loss. We aimed to investigate metabolites in arthritic mice urine as biomarkers of muscle loss. DBA1/J mice comprised collagen-induced arthritis (CIA) and control (CO) groups. Urine samples were collected at 0, 18, 35, 45, 55, and 65 days of disease and subjected to nuclear magnetic resonance spectroscopy. Metabolites were identified using Chenomx and Birmingham Metabolite libraries. The statistical model used principal component analysis, partial least-squares discriminant analysis, and partial least-squares regression analysis. Linear regression and Fisher's exact test via the MetaboAnalyst website were performed (VIP-score). Nearly 100 identified metabolites had CIA vs. CO and disease time-dependent differences (

Indexed as

biomarkerscachexiaCIAmetabolomicsNMRprecision medicinerheumatoid arthritis

Identifiers

PMID34575614
PMCPMC8464712
OpenAlexW3195628163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.